- Home
- SANW vs ABVC Comparison
SANW vs ABVC Comparison
Compare SANW & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANW
- ABVC
- Stock Information
- Founded
- SANW 1980
- ABVC 2015
- Country
- SANW United States
- ABVC United States
- Employees
- SANW N/A
- ABVC N/A
- Industry
- SANW Farming/Seeds/Milling
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SANW Consumer Staples
- ABVC Health Care
- Exchange
- SANW Nasdaq
- ABVC Nasdaq
- Market Cap
- SANW 18.8M
- ABVC 16.7M
- IPO Year
- SANW 2010
- ABVC N/A
- Fundamental
- Price
- SANW $5.57
- ABVC $1.32
- Analyst Decision
- SANW Strong Buy
- ABVC
- Analyst Count
- SANW 1
- ABVC 0
- Target Price
- SANW $35.00
- ABVC N/A
- AVG Volume (30 Days)
- SANW 8.9K
- ABVC 213.2K
- Earning Date
- SANW 05-13-2025
- ABVC 04-30-2025
- Dividend Yield
- SANW N/A
- ABVC N/A
- EPS Growth
- SANW N/A
- ABVC N/A
- EPS
- SANW N/A
- ABVC N/A
- Revenue
- SANW $54,809,365.00
- ABVC $508,383.00
- Revenue This Year
- SANW N/A
- ABVC $735.18
- Revenue Next Year
- SANW $14.25
- ABVC N/A
- P/E Ratio
- SANW N/A
- ABVC N/A
- Revenue Growth
- SANW N/A
- ABVC 1904.43
- 52 Week Low
- SANW $2.10
- ABVC $0.40
- 52 Week High
- SANW $11.60
- ABVC $1.40
- Technical
- Relative Strength Index (RSI)
- SANW 50.04
- ABVC 71.45
- Support Level
- SANW $4.83
- ABVC $1.01
- Resistance Level
- SANW $6.83
- ABVC $1.00
- Average True Range (ATR)
- SANW 0.65
- ABVC 0.09
- MACD
- SANW 0.15
- ABVC 0.03
- Stochastic Oscillator
- SANW 44.74
- ABVC 92.78
About SANW S&W Seed Company (NV)
S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.